文献速递哮喘

气道细胞中miR-200b-3p的A-to-I编辑与中重度哮喘相关

A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
PubMed 文献 · Eur Respir J · 2021-07-29

该研究在142例成人哮喘病例和对照的支气管上皮细胞中鉴定miRNA的A-to-I编辑位点,发现miR-200b-3p第5位点编辑频率在病例中降低,尤其在中度和重度哮喘中,且与SOCS1表达升高及肺泡灌洗液嗜酸性粒细胞水平相关。

要点

  • miR-200b-3p第5位点A-to-I编辑频率降低与中重度哮喘相关。
  • 编辑后的miR-200b-3p预测靶基因富集于IL-4和IFN-γ信号通路,包括SOCS1。
  • SOCS1在中重度哮喘中表达升高,且与BALF嗜酸性粒细胞水平相关。

核心结论

  • 中重度哮喘者下气道细胞中miR-200b-3p第5位点A-to-I编辑减少,可能导致SOCS1过表达和细胞因子信号受损。
  • ADAR介导的编辑可能是成人中重度哮喘特征的表观遗传机制。

研究设计与样本

  • 研究纳入142例成人哮喘病例和对照,检测支气管上皮细胞中miRNA的A-to-I编辑位点。
  • 分析编辑位点与哮喘严重程度及临床指标的关联,并用配对RNA测序数据进行通路富集和靶基因关联分析。

主要发现

  • 在miRNA中检测到19个A-to-I编辑位点,其中miR-200b-3p第5位点在病例中编辑频率低于对照(pcorrected=0.013)。
  • 该位点编辑频率在中度哮喘(pcorrected=0.029)和重度哮喘(pcorrected=3.9×10-4)中低于对照,轻度哮喘无显著差异(pcorrected=0.38)。
  • 编辑后的miR-200b-3p预测有232个靶基因,富集于IL-4和IFN-γ信号通路,包括SOCS1。
  • SOCS1在中度哮喘(pcorrected=0.017)和重度哮喘(pcorrected=5.4×10-3)中表达高于对照。
  • miR-200b-3p编辑和SOCS1均与支气管肺泡灌洗液嗜酸性粒细胞水平相关。

临床怎么用

  • 该发现提示ADAR介导的miR-200b-3p编辑可能作为中重度哮喘的潜在生物标志物或治疗靶点,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Asthma is a chronic lung disease characterised by persistent airway inflammation. Altered microRNA (miRNA)-mediated gene silencing in bronchial epithelial cells (BECs) has been reported in asthma, yet adenosine deaminase acting on RNA (ADAR)-mediated miRNA editing in asthma remains unexplored. METHODS: We first identified adenosine to inosine (A-to-I) edited sites in miRNAs in BECs from 142 adult asthma cases and controls. A-to-I edited sites were tested for associations with asthma severity and clinical measures of asthma. Paired RNA sequencing data were used to perform pathway enrichments and test for associations with bioinformatically predicted target genes of the unedited and edited miRNAs. RESULTS: Of 19 A-to-I edited sites detected in these miRNAs, one site at position 5 of miR-200b-3p was edited less frequently in cases compared with controls (pcorrected=0.013), and especially compared with cases with moderate (pcorrected=0.029) and severe (pcorrected=3.9×10-4), but not mild (pcorrected=0.38), asthma. Bioinformatic prediction revealed 232 target genes of the edited miR-200b-3p, which were enriched for both interleukin-4 and interferon-γ signalling pathways, and included the SOCS1 (suppressor of cytokine signalling 1) gene. SOCS1 was more highly expressed in moderate (pcorrected=0.017) and severe (pcorrected=5.4×10-3) asthma cases compared with controls. Moreover, both miR-200b-3p editing and SOCS1 were associated with bronchoalveolar lavage eosinophil levels. CONCLUSIONS: Reduced A-to-I editing of position 5 of miR-200b-3p in lower airway cells from moderate-to-severe asthmatic subjects may lead to overexpression of SOCS1 and impaired cytokine signalling. We propose ADAR-mediated editing as an epigenetic mechanism contributing to features of moderate-to-severe asthma in adulthood.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Magnaye KM, Naughton KA, Huffman J, et al. A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma. Eur Respir J. 2021. PMID: 33446603. doi:10.1183/13993003.03862-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。